Summary - Funding Rounds

Founding Date

2014
Akarna Therapeutics is a subsidiary of Allergan

Akarna Therapeutics Balance Sheet

Annual

GBPFY, 2016FY, 2017FY, 2018

Cash

6.1m63.3k519.0k

Accounts Receivable

481.4k

Current Assets

6.1m5.6m5.3m

Total Assets

6.1m5.6m5.3m

Current Liabilities

226.5k16.1k

Total Liabilities

226.5k16.1k

Common Stock

101.0101.0101.0

Retained Earnings

(9.0m)(9.3m)(9.6m)

Total Equity

5.9m5.6m5.3m

Financial Leverage

1 x1 x1 x